Towards the development of an immuno MALDI (iMALDI) mass spectrometry assay for the diagnosis of hypertension.
about
The application of Gaussian mixture models for signal quantification in MALDI-TOF mass spectrometry of peptidesImmune-enrichment of insulin in bio-fluids on gold-nanoparticle decorated target plate and in situ detection by MALDI MSEfficient sample preparation in immuno-matrix-assisted laser desorption/ionization mass spectrometry using acoustic trapping.Mass spectrometric immunoassay and MRM as targeted MS-based quantitative approaches in biomarker development: potential applications to cardiovascular disease and diabetesReconstructing the pipeline by introducing multiplexed multiple reaction monitoring mass spectrometry for cancer biomarker verification: an NCI-CPTC initiative perspective.Development and evaluation of an immuno-MALDI (iMALDI) assay for angiotensin I and the diagnosis of secondary hypertensionThe Human Proteome Organization Chromosome 6 Consortium: integrating chromosome-centric and biology/disease driven strategiesMALDI-TOF MS profiling as the first-tier screen for sickle cell disease in neonates: matching throughput to objectives.Combining ultracentrifugation and peptide termini group-specific immunoprecipitation for multiplex plasma protein analysis.Mass-spectrometry-based clinical proteomics--a review and prospective.Thin-layer matrix sublimation with vapor-sorption induced co-crystallization for sensitive and reproducible SAMDI-TOF MS analysis of protein biosensors.On-target and nanoparticle-facilitated selective enrichment of peptides and proteins for analysis by MALDI-MS.Analytical validation considerations of multiplex mass-spectrometry-based proteomic platforms for measuring protein biomarkers.Development of a MALDI-TOF MS strategy for the high-throughput analysis of biomarkers: on-target aptamer immobilization and laser-accelerated proteolysis.Matrix-assisted laser desorption/ionization for simultaneous quantitation of (acyl-)carnitines and organic acids in dried blood spots.Targeted quantitative mass spectrometric immunoassay for human protein variants.The path to clinical proteomics research: integration of proteomics, genomics, clinical laboratory and regulatory science.Quantitative mass spectrometric immunoassay for the chemokine RANTES and its variants.A novel strategy for the rapid preparation and isolation of intact immune complexes from peptide mixtures.Peptide immunoaffinity enrichment coupled with mass spectrometry for peptide and protein quantification.High-throughput workflow for identification of phosphorylated peptides by LC-MALDI-TOF/TOF-MS coupled to in situ enrichment on MALDI plates functionalized by ion landing.Molecularly imprinted polymers coupled to matrix assisted laser desorption ionization mass spectrometry for femtomoles detection of cardiac troponin I peptides.Development of multiplex mass spectrometric immunoassay for detection and quantification of apolipoproteins C-I, C-II, C-III and their proteoformsAdvances in Proteomic Technologies and Its Contribution to the Field of CancerAssuring Consistent Performance of an Insulin-Like Growth Factor 1 MALDImmunoassay by Monitoring Measurement Quality IndicatorsPolyclonal antibody to soman-tyrosine.Revealing plant defense signaling: getting more sophisticated with phosphoproteomics.Mass spectrometry-based targeted quantitative proteomics: achieving sensitive and reproducible detection of proteins.The current status of clinical proteomics and the use of MRM and MRM(3) for biomarker validation.Proteomics in hypertension and other cardiovascular diseases.Targeted quantitation of CVD-linked plasma proteins for biomarker verification and validation.Pre-analytical and analytical variability in absolute quantitative MRM-based plasma proteomic studies.Clinical applications of MS-based protein quantification.Current trends in quantitative proteomics - an update.Combining bioinformatics and MS-based proteomics: clinical implications.Peptide and Protein Quantification Using Automated Immuno-MALDI (iMALDI).
P2860
Q28544751-06633F93-ED13-4F62-A032-41A18E29334EQ28818783-16253E86-A8ED-481A-AA5F-5500BAEC1706Q30441133-F4426139-A3DC-43E5-84C8-1EE5B57A8A8FQ33643266-309B1317-F1BD-4554-9B5B-063CB8C7FA1DQ33669587-2DD7ABD1-F304-40CA-BEA4-9CA19D8EB988Q33845414-D215C3EA-CAC4-46B7-851B-B862518F2F4DQ33897503-1B53016C-6066-496C-865D-CDBC329BF5FDQ33959640-1CFA3822-5FE7-4730-AC7D-602914C72A0EQ34242987-5C414753-B690-4C03-9C75-E08F190C671FQ34252113-F29B75DD-C179-4173-8A25-FACEEE805AA9Q34357363-6A42CBFD-09FE-4B2C-BB6A-A0A4A0F6E836Q34466472-305211E4-1692-42FC-9D3F-FC632352D020Q34669490-CF960B96-FABE-4DBB-8504-DE1FD4F2DBBDQ34682121-C93F7DCE-1D54-4D23-9743-F4A727F9A3C8Q34748605-FD94A225-ABFB-4A83-ACA1-A59F98B9BDDAQ34825391-3AF60FEF-DCF8-4A25-90D0-64C8889A4984Q35048047-B8F57973-07B2-4D2D-A326-41DDB6A3DC12Q35166976-C3E17D61-09A8-4372-B58E-93BE946B1FF3Q35209717-4A4A1205-A717-4B49-B280-951B951F7262Q35264312-B5E42412-A015-4156-AFCD-0C5DF831BCECQ35689863-E74B749D-DC07-42AA-8B55-3A40FFE4702DQ35776559-871BC1F4-03BE-4313-AADB-05433C315A1AQ36072219-0B111556-7A71-46E1-9123-6B1EB559F4E0Q36112651-6431D2F6-53E0-4993-A1AC-BA6EB48B374CQ36361741-3DA86E40-4DC8-4DC9-9DBD-309B8083BE53Q37067404-77776628-C3A7-47F7-A033-2708F3123DD4Q37928311-2A9C18F5-5812-4302-A370-907767442A56Q38009277-CE7F6C58-DACF-44CB-9641-C2400665D6EDQ38012171-8BF5BE03-21B1-4D81-993E-DE5401BFC441Q38020003-06FC407F-C6D5-4ACE-9574-641A2BAD85BBQ38160931-B7B5E0B9-C887-43DD-931C-E82E8AA04201Q38164428-6E9E2BEF-E819-4B73-9F2B-119BBD743D89Q38802991-6EF3ECD0-82D1-4948-9C37-2536ED2A3554Q38832695-15024537-06C2-4759-8F8A-301F126E7F4EQ42653805-F42DBFC1-41C8-4FA6-BF9F-EA71BCD6A7B6Q47855872-0922A417-D2FB-44F8-81AB-003C39FBBB5B
P2860
Towards the development of an immuno MALDI (iMALDI) mass spectrometry assay for the diagnosis of hypertension.
description
2010 nî lūn-bûn
@nan
2010 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
name
Towards the development of an ...... the diagnosis of hypertension.
@ast
Towards the development of an ...... the diagnosis of hypertension.
@en
type
label
Towards the development of an ...... the diagnosis of hypertension.
@ast
Towards the development of an ...... the diagnosis of hypertension.
@en
prefLabel
Towards the development of an ...... the diagnosis of hypertension.
@ast
Towards the development of an ...... the diagnosis of hypertension.
@en
P2093
P2860
P1476
Towards the development of an ...... the diagnosis of hypertension.
@en
P2093
Brinda Shah
Christoph H Borchers
D Randal Mason
Daniel T Holmes
Jennifer D Reid
P2860
P2888
P304
P356
10.1016/J.JASMS.2010.01.024
P577
2010-02-01T00:00:00Z
P5875
P6179
1032278566